Abstract
Purpose Having a child with cancer can profoundly impact parents’ health-related quality of life (HRQOL). However, there is a lack of knowledge about the long-term effects of childhood cancer on parents’ well-being. The current study aimed to 1) describe the HRQOL of parents of long-term childhood cancer survivors (CCS) and compare it with that of parents from the general population in Switzerland, and 2) investigate sociodemographic and cancer-related determinants of lower HRQOL in parents of CCS.
Methods In this cross-sectional study, a total of 751 parents of CCS (mean time since diagnosis = 23.7 years, SD = 6.7 years) and 454 parents from the general population reported their HRQOL by completing the Short Form-36 (SF-36v2). Sociodemographic and cancer-related characteristics were also collected.
Results Multilevel regression analyses showed that parents of CCS and parents from the general population had similar physical and mental HRQOL. When comparing mothers and fathers separately, there were no differences between the samples, except for higher HRQOL in the domain of physical functioning in mothers of CCS. Cancer-related characteristics were not associated with HRQOL in parents of CCS. Several sociodemographic characteristics such as being female, being from the French or Italian-speaking part of Switzerland, having a lower education, having a chronic condition, and having a migration background were associated with lower HRQOL.
Conclusion Parents of CCS are doing well a long time after their child’s cancer diagnosis. Nevertheless, tailored support should be provided for at-risk demographic groups.
Plain English summary Having a child with cancer might have a profound impact on various aspects of parents’ well-being, including their quality of life. However, not much is known about how parents are doing very long after their child’s cancer diagnosis. Our study aimed to describe the quality of life of parents of childhood cancer survivors and compare it to that of parents from the general population. Furthermore, we sought to compare mothers and fathers separately. We conducted a questionnaire survey with 751 parents of childhood cancer survivors, on average 24 years after the diagnosis. Additionally, 454 parents from the general population completed a similar questionnaire. We found that parents of survivors reported a similar quality of life to parents from the general population. When comparing mothers and fathers separately, we found no differences between the samples, except for higher quality of life in the domain of physical functioning among mothers of survivors compared to mothers of the general population. We conclude that overall, parents of childhood cancer survivors are doing well long after their child’s cancer diagnosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Swiss National Science Foundation (Grant Number 100019_153268/1), Kinderkrebshilfe Schweiz, and Swiss Cancer Research (KFS-5384-08-2021).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The SCCSS-Parents study was reviewed and approved by the Ethikkommission Nordwest- und Zentralschweiz (EKNZ) on 26 March 2015 (Reference: EKNZ 2015-075).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* shared last authorship
